Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

KIF1A Gene (HSN2C) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين KIF1A (HSN2C) بتقنية التسلسل الجيني القادم (NGS) في الإمارات | ٢٨٠٠ درهم | معتمد من هيئة الصحة بدبي

Executive Summary | ملخص تنفيذي

فحص طبي وراثي متطور لتشخيص الطفرات في جين KIF1A المرتبطة بالاعتلالات العصبية الوراثية مثل الشلل النصفي التشنجي الوراثي والاعتلال العصبي الحسي الوراثي. يُجرى وفق أعلى معايير الجودة الإماراتية بدقة تشخيصية تصل إلى ٩٩.٩٪ تحت إشراف أطباء مرخصين من هيئة الصحة بدبي.

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
  • Premium Logistics: Paid Hospital-Grade Home Collection (8 AM – 11 PM) via ISO Certified Cold-Chain & VIP Mobile Phlebotomy.
  • Clinical Guidance: Telephonic Post-Test Clinical Correlation Session with a Molecular Pathologist.
  • Insurance: Direct Billing Verification – WhatsApp +971 54 548 8731.

Overview

The KIF1A Gene (HSN2C) Next‑Generation Sequencing (Genetic Test provides definitive molecular diagnosis, enabling targeted clinical management, genetic counselling, and family planning.

تحليل جين KIF1A بتقنية التسلسل الجيني المتقدم (NGS) يُعد الفحص الأكثر دقة لتحديد الطفرات المسببة للأمراض العصبية الوراثية في الإمارات.

Feature Our KIF1A NGS Test Closest Alternative (Multi‑Gene Panel / WES)
Target ResolutionFull coding region ± 50 bp intronic flanks; deep coverage ≥ 100xVariable coverage; may miss deep intronic or regulatory variants
Analytical Sensitivity>99.9% for single nucleotide variants & indels~95–98% depending on capture design
Turnaround Time3–4 Weeks4–8 Weeks (WES) / 2–4 Weeks (Panel)
Pre‑test Genetic CounsellingMandatory UAE‑compliant genetic counselling & pedigree chartingOften optional or not included
UAE Regulatory AlignmentFull DHA/MOHAP & CDS Law 2026 (Minors) adherenceVariable

Physician Insight & Safety Protocol

“Genetic testing for KIF1A‑related disorders is a deeply personal decision. As your consulting neurologist, I urge every family to view this result not as a label, but as a roadmap toward precise care. Always correlate molecular findings with your clinical picture – no single gene dictates your future. We are here to interpret these results with empathy and clinical wisdom.”

— Dr. PRABHAKAR REDDY, DHA Lic. 61713011 (Consultant Neurologist)

Medication Warning

Do not discontinue or modify any prescribed neurological medication based on this test result without a face‑to‑face consultation with your treating physician.

Exclusion Criteria (Test May Be Refused)

  • Sample without documented clinical history or genetic counselling note (UAE CDS Law 2026).
  • Minors lacking formal guardian consent as per Federal Decree‑Law No. 41 of 2024, Art. 87.
  • Specimens not collected in DHA‑approved cold‑chain logistics (e.g., FTA card not dried properly).
  • Self‑collection without prior instruction & video verification (when applicable).

Emergency Red Flags – Seek Immediate Medical Attention

  • Sudden onset paralysis or acute muscle weakness.
  • New‑onset seizures or loss of consciousness.
  • Rapid cognitive decline or speech arrest.
  • Unexplained fever with stiff neck and photophobia.

Patient FAQ & Clinical Guidance

What is the KIF1A gene test, and who should consider it?

The KIF1A gene test is a DNA sequencing assay that identifies disease‑causing mutations in the KIF1A gene, aiding diagnosis of hereditary spastic paraplegia and sensory neuropathies. Individuals with early‑onset gait disturbance, progressive spasticity, or a family history of undiagnosed neurological decline should consider this test. Clinical genetic counselling is mandatory before sampling.

ما هي طريقة سحب العينة لتحليل KIF1A؟

يُمكن إجراء الفحص باستخدام عينة دم كامل تُسحب من الوريد أو بقعة دم جافة على بطاقة FTA، أو حمض نووي مستخلص مُسبقاً، مع ضرورة الالتزام بالنقل المُبرد وفق معايير الآيزو. يُوصى بإتمام جلسة استشارة وراثية قبل أخذ العينة لضمان اكتمال التاريخ الطبي ورسم شجرة العائلة.

How long does it take to receive results, and will a doctor explain them?

Standard reporting time is 3 to 4 weeks from sample accession. Every report includes a telephonic post‑test guidance session with a clinical geneticist or molecular pathologist who will translate the findings into your clinical context, outline recurrence risks, and suggest next steps. This service is included in the 2800 AED fee.

UAE Regulatory & Quality Compliance

  • Licensed by DHA under Facility License No. 9834453.
  • Processing in strict accordance with Federal Decree‑Law No. 41 of 2024, Art. 87 (Genetic Testing & Minors).
  • Full compliance with UAE Personal Data Protection Law (PDPL) – your genomic data is never shared without explicit consent.
  • ISO 9001:2015 Certified Quality Management System (Cert: INT/EGQ/2509DA/3139).
  • All collection kits follow CDS Law 2026 regulations for handling of minors’ samples.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians